4//SEC Filing
Conatus Pharmaceuticals Inc 4
Accession 0001209191-14-014153
CIK 0001383701operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:37 PM ET
Size
15.8 KB
Accession
0001209191-14-014153
Insider Transaction Report
Form 4
KLINGENSTEIN PAUL H
Director10% Owner
Transactions
- Other
Common Stock
2014-02-19−30,216→ 22,203 total(indirect: By Aberdare Partners III, L.P.) - Other
Common Stock
2014-02-19+36,634→ 36,634 total(indirect: By Aberdare GP III, L.L.C.) - Other
Common Stock
2014-02-19−36,634→ 0 total(indirect: By Aberdare GP III, L.L.C.) - Other
Common Stock
2014-02-19+8,731→ 8,731 total(indirect: By Trust) - Other
Common Stock
2014-02-19−1,283,589→ 943,355 total(indirect: By Aberdare Ventures III, L.P.) - Other
Common Stock
2014-02-19+20,322→ 20,322 total
Footnotes (7)
- [F1]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Aberdare Ventures III, L.P. ("Aberdare Ventures III") without consideration to its limited partners and its general partner, Aberdare GP III, L.L.C. ("Aberdare GP III").
- [F2]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Aberdare Partners III, L.P. ("Aberdare Partners III") without consideration to its limited partners and its general partner, Aberdare GP III.
- [F3]The Reporting Person is a Managing Director of Aberdare GP III, L.L.C. ("Aberdare GP III") which serves as the sole General Partner of Aberdare Ventures III and Aberdare Partners III. As such, the Reporting Person shares voting and investment control over the securities owned by Aberdare Ventures III and Aberdare Partners III, and may be deemed to own beneficially the securities held by Aberdare Ventures III and Aberdare Partners III. The Reporting Person disclaims beneficial ownership of the shares held by Aberdare Ventures III and Aberdare Partners III except to the extent of his proportionate pecuniary interest therein.
- [F4]Represents a change in the form of ownership from indirect to direct by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer by Aberdare Ventures III and Aberdare Partners III described in footnotes 1 and 2.
- [F5]Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Aberdare GP III without consideration to its members.
- [F6]Represents a change in the form of ownership from indirect to direct by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer by Aberdare GP III described in footnote 5.
- [F7]Represents a change in the form of ownership from indirect to direct by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer by Aberdare GP III described in footnote 5. The shares are held by the Klingenstein-Bole 2003 Irrevocable Children's Trust (the "Trust"). The Reporting Person is a trustee of the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.
Documents
Issuer
Conatus Pharmaceuticals Inc
CIK 0001383701
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001383701
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:37 PM ET
- Size
- 15.8 KB